长期1型糖尿病研究的发现
本文综述了长期1型糖尿病幸存者研究中的选择偏倚来源,包括早发糖尿病选择、发病-患病率偏倚和队列随访丢失偏倚,并总结了关于胰岛素产生自然史、微血管并发症抵抗及潜在机制的研究发现,提示未来治疗靶点。
要点
- 长期1型糖尿病研究存在选择偏倚,需注意早发选择、发病-患病率偏倚和随访丢失偏倚。
- 部分长期幸存者保留胰岛素产生并抵抗微血管并发症,相关机制可能成为治疗靶点。
- 潜在机制包括维持β细胞、激活丙酮酸激酶M2、修饰AGE及RAAS激活等。
核心结论
- 长期1型糖尿病幸存者研究揭示了与保留胰岛素产生和抵抗并发症相关的 putative 机制,可能成为未来治疗靶点。
研究设计与样本
- 本文为综述,总结了长期1型糖尿病幸存者研究的方法学偏倚来源及文献发现。
主要发现
- 长期幸存者中存在保留胰岛素产生和抵抗微血管并发症的现象。
- 研究提示多种机制:维持或恢复β细胞功能、激活丙酮酸激酶M2、修饰AGE产生与处理、调节RAAS激活(可能正常化入球而非出球肾小动脉阻力)、以及视黄醇结合和DNA损伤检查点蛋白的激活与修饰。
临床怎么用
- 临床关注长期1型糖尿病幸存者的胰岛素保留和并发症抵抗表型,并注意幸存者研究的选择偏倚。
局限性
- 幸存者研究存在选择偏倚,包括早发糖尿病选择、发病-患病率偏倚和队列随访丢失偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Award programmes that acknowledge the remarkable accomplishments of long-term survivors with type 1 diabetes have naturally evolved into research programmes to determine the factors associated with survivorship and resistance to chronic complications. In this review, we present an overview of the methodological sources of selection bias inherent in survivorship research (selection of those with early-onset diabetes, incidence-prevalence bias and bias from losses to follow-up in cohort studies) and the breadth and depth of literature focusing on this special study population. We focus on the learnings from the study of longstanding type 1 diabetes on discoveries about the natural history of insulin production loss and microvascular complications, and mechanisms associated with them that may in future offer therapeutic targets. We detail descriptive findings about the prevalence of preserved insulin production and resistance to complications, and the putative mechanisms associated with such resistance. To date, findings imply that the following mechanisms exist: strategies to maintain or recover beta cells and their function; activation of specific glycolytic enzymes such as pyruvate kinase M2; modification of AGE production and processing; novel mechanisms for modification of renin-angiotensin-aldosterone system activation, in particular those that may normalise afferent rather than efferent renal arteriolar resistance; and activation and modification of processes such as retinol binding and DNA damage checkpoint proteins. Among the many clinical and public health insights, research into this special study population has identified putative mechanisms that may in future serve as therapeutic targets, knowledge that likely could not have been gained without studying long-term survivors.
引用
- Perkins BA, Lovblom LE, Lanctôt SO, et al. Discoveries from the study of longstanding type 1 diabetes. Diabetologia. 2021. PMID: 33661335. doi:10.1007/s00125-021-05403-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。